STOCK TITAN

[Form 4] Insulet Corporation Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Insulet Corporation (PODD) Form 4 shows insider transactions by Laetitia Cousin, SVP, Regulatory, Quality & Compliance, dated 09/08/2025. The filing reports the acquisition of 541 shares via an employee stock option exercisable at $276.36 and 256 shares via a separate option exercisable at $166.62, both effective 09/08/2025. The reporting person also acquired 541 and 256 shares (reported as non-derivative acquisitions) at those prices and sold 797 shares on the same date at a weighted average price of $348.81. The filing discloses that 93 of the acquired shares were purchased under the company stock purchase plan since the last Section 16 filing. Following the reported transactions, beneficial ownership figures are shown as 4,431; 4,687; and 3,890 shares on the respective lines. The transactions include annual non-qualified option awards that vest in four substantially equal annual installments.

Insulet Corporation (PODD) — Il Form 4 riporta transazioni interne effettuate da Laetitia Cousin, SVP Regulatory, Quality & Compliance, in data 08/09/2025. La comunicazione segnala l’acquisto di 541 azioni mediante l’esercizio di un’opzione azionaria dipendenti con prezzo di esercizio di $276,36 e di 256 azioni mediante un’altra opzione con prezzo di esercizio di $166,62, entrambe efficaci il 08/09/2025. La persona segnalante ha registrato tali 541 e 256 azioni come acquisizioni non-derivative ai rispettivi prezzi e ha venduto 797 azioni nella stessa data a un prezzo medio ponderato di $348,81. Il filing indica inoltre che 93 delle azioni acquisite sono state comprate tramite il piano di acquisto azionario aziendale dalla precedente dichiarazione ai sensi della Sezione 16. Dopo queste operazioni, la titolarità beneficiaria risultante è rispettivamente di 4.431, 4.687 e 3.890 azioni sulle righe corrispondenti. Le transazioni includono premi annuali di opzioni non qualificate che maturano in quattro tranche annuali sostanzialmente uguali.

Insulet Corporation (PODD) — El Formulario 4 muestra transacciones internas de Laetitia Cousin, SVP de Regulatory, Quality & Compliance, con fecha 08/09/2025. La presentación informa la adquisición de 541 acciones tras ejercer una opción sobre acciones de empleados a $276.36 y 256 acciones mediante otra opción a $166.62, ambas efectivas el 08/09/2025. La persona informante también registró esas 541 y 256 acciones como adquisiciones no derivadas a esos precios y vendió 797 acciones en la misma fecha a un precio promedio ponderado de $348.81. El filing revela además que 93 de las acciones adquiridas se compraron mediante el plan de compra de acciones de la compañía desde la última presentación bajo la Sección 16. Tras las operaciones declaradas, la titularidad beneficiaria aparece como 4.431; 4.687; y 3.890 acciones en las respectivas líneas. Las transacciones incluyen concesiones anuales de opciones no calificadas que vencen en cuatro cuotas anuales sustancialmente iguales.

Insulet Corporation (PODD) — Form 4는 2025년 9월 8일자 Laetitia Cousin(규제·품질·준수 담당 수석 부사장)의 내부거래를 보고합니다. 제출서류에 따르면 직원스톡옵션 행사로 행사가격 $276.36에 541주, 별도 옵션을 통해 행사가격 $166.62에 256주를 각각 취득했으며 두 거래 모두 2025-09-08부로 효력이 발생했습니다. 보고인은 해당 541주와 256주를 해당 가격으로 비파생(직접) 취득으로 기재했고, 같은 날 가중평균가 $348.81로 797주를 매도했습니다. 제출서류에는 취득한 주식 중 93주가 마지막 섹션16 신고 이후 회사 주식매입제도를 통해 구입되었다고 밝혀져 있습니다. 보고된 거래 이후 수혜적 보유 주식수는 각각 4,431; 4,687; 및 3,890주로 기재되어 있습니다. 거래에는 4년에 걸쳐 거의 동일한 비율로 베스팅되는 연간 비자격 옵션 부여도 포함됩니다.

Insulet Corporation (PODD) — Le Formulaire 4 fait état des opérations d’initié réalisées par Laetitia Cousin, SVP Regulatory, Quality & Compliance, en date du 08/09/2025. Le dépôt rapporte l’acquisition de 541 actions par l’exercice d’une option salarié au prix d’exercice de 276,36 $ et de 256 actions par une autre option au prix d’exercice de 166,62 $, toutes deux effectives le 08/09/2025. La personne déclarant a également inscrit ces 541 et 256 actions comme acquisitions non dérivées à ces prix et a vendu 797 actions le même jour à un prix moyen pondéré de 348,81 $. Le dépôt précise en outre que 93 des actions acquises ont été achetées dans le cadre du plan d’achat d’actions de la société depuis le dernier dépôt au titre de la Section 16. Après les opérations déclarées, la détention bénéficiaire est indiquée respectivement à 4 431 ; 4 687 ; et 3 890 actions sur les lignes correspondantes. Les transactions comprennent des attributions annuelles d’options non qualifiées qui acquièrent droit en quatre versements annuels substantiellement égaux.

Insulet Corporation (PODD) — Das Form 4 dokumentiert Insider-Transaktionen von Laetitia Cousin, SVP Regulatory, Quality & Compliance, datiert 08.09.2025. Die Einreichung meldet den Erwerb von 541 Aktien durch Ausübung einer Mitarbeiter-Aktienoption zu einem Ausübungspreis von $276,36 und 256 Aktien durch eine weitere Option zu $166,62, beide mit Wirkung zum 08.09.2025. Die meldepflichtige Person hat diese 541 und 256 Aktien als nicht-derivative Erwerbe zu diesen Preisen angegeben und am selben Tag 797 Aktien zu einem gewichteten Durchschnittspreis von $348,81 verkauft. In der Einreichung wird außerdem offengelegt, dass 93 der erworbenen Aktien seit der letzten Section-16-Meldung über den Aktienkaufplan des Unternehmens erworben wurden. Nach den gemeldeten Transaktionen beträgt das wirtschaftliche Eigentum auf den jeweiligen Zeilen 4.431; 4.687; und 3.890 Aktien. Die Transaktionen umfassen jährliche nicht-qualifizierte Optionszuteilungen, die in vier im Wesentlichen gleichen jährlichen Raten vesten.

Positive
  • Option exercises and share acquisitions were executed, increasing the reporting person's stake before the sale (541 and 256 shares acquired via options).
  • Employee Stock Purchase Plan participation: 93 shares purchased since the last Section 16 filing, showing continued insider participation in company equity.
  • Clear disclosures including exercise prices, sale weighted-average price, and explanatory notes offering per-price sale details on request.
Negative
  • Insider sale of 797 shares at a weighted average price of $348.81 reduced reported holdings to as low as 3,890 shares on one line.
  • No broader company context is provided in the filing to explain the rationale for the sale, limiting interpretability of insider intent.

Insights

TL;DR: Routine insider option exercises, purchases and a partial sale; represents personal rebalancing rather than a clearly material corporate event.

The filing documents standard Section 16 activity: option grants becoming exercisable and exercises at strike prices of $276.36 and $166.62, concurrent non-derivative acquisitions, and a sale of 797 shares at a weighted average of $348.81. The inclusion of 93 shares from the Employee Stock Purchase Plan is disclosed. These actions alter the reporting person’s direct holdings (reported on separate lines as 4,431; 4,687; and 3,890 shares) but do not, by themselves, disclose any company-level operational or financial change. For investors, this is useful for tracking insider ownership and timing of option exercises, but it is routine in nature and does not indicate a material change to Insulet’s capital structure or operations.

TL;DR: Compliance appears complete: Form 4 reports option awards, exercises, ESPP purchases and a sale with explanatory notes.

The Form 4 includes clear disclosures: transaction codes, exercise prices, weighted-average sale price range, and an explanatory note committing to provide per-price sale details if requested. The filing identifies the reporting person’s role and uses attorney-in-fact signature. The presence of annual non-qualified option awards with four-year vesting is documented. From a governance perspective, the form meets disclosure norms under Section 16; no governance issues or exceptions are reported within the filing text.

Insulet Corporation (PODD) — Il Form 4 riporta transazioni interne effettuate da Laetitia Cousin, SVP Regulatory, Quality & Compliance, in data 08/09/2025. La comunicazione segnala l’acquisto di 541 azioni mediante l’esercizio di un’opzione azionaria dipendenti con prezzo di esercizio di $276,36 e di 256 azioni mediante un’altra opzione con prezzo di esercizio di $166,62, entrambe efficaci il 08/09/2025. La persona segnalante ha registrato tali 541 e 256 azioni come acquisizioni non-derivative ai rispettivi prezzi e ha venduto 797 azioni nella stessa data a un prezzo medio ponderato di $348,81. Il filing indica inoltre che 93 delle azioni acquisite sono state comprate tramite il piano di acquisto azionario aziendale dalla precedente dichiarazione ai sensi della Sezione 16. Dopo queste operazioni, la titolarità beneficiaria risultante è rispettivamente di 4.431, 4.687 e 3.890 azioni sulle righe corrispondenti. Le transazioni includono premi annuali di opzioni non qualificate che maturano in quattro tranche annuali sostanzialmente uguali.

Insulet Corporation (PODD) — El Formulario 4 muestra transacciones internas de Laetitia Cousin, SVP de Regulatory, Quality & Compliance, con fecha 08/09/2025. La presentación informa la adquisición de 541 acciones tras ejercer una opción sobre acciones de empleados a $276.36 y 256 acciones mediante otra opción a $166.62, ambas efectivas el 08/09/2025. La persona informante también registró esas 541 y 256 acciones como adquisiciones no derivadas a esos precios y vendió 797 acciones en la misma fecha a un precio promedio ponderado de $348.81. El filing revela además que 93 de las acciones adquiridas se compraron mediante el plan de compra de acciones de la compañía desde la última presentación bajo la Sección 16. Tras las operaciones declaradas, la titularidad beneficiaria aparece como 4.431; 4.687; y 3.890 acciones en las respectivas líneas. Las transacciones incluyen concesiones anuales de opciones no calificadas que vencen en cuatro cuotas anuales sustancialmente iguales.

Insulet Corporation (PODD) — Form 4는 2025년 9월 8일자 Laetitia Cousin(규제·품질·준수 담당 수석 부사장)의 내부거래를 보고합니다. 제출서류에 따르면 직원스톡옵션 행사로 행사가격 $276.36에 541주, 별도 옵션을 통해 행사가격 $166.62에 256주를 각각 취득했으며 두 거래 모두 2025-09-08부로 효력이 발생했습니다. 보고인은 해당 541주와 256주를 해당 가격으로 비파생(직접) 취득으로 기재했고, 같은 날 가중평균가 $348.81로 797주를 매도했습니다. 제출서류에는 취득한 주식 중 93주가 마지막 섹션16 신고 이후 회사 주식매입제도를 통해 구입되었다고 밝혀져 있습니다. 보고된 거래 이후 수혜적 보유 주식수는 각각 4,431; 4,687; 및 3,890주로 기재되어 있습니다. 거래에는 4년에 걸쳐 거의 동일한 비율로 베스팅되는 연간 비자격 옵션 부여도 포함됩니다.

Insulet Corporation (PODD) — Le Formulaire 4 fait état des opérations d’initié réalisées par Laetitia Cousin, SVP Regulatory, Quality & Compliance, en date du 08/09/2025. Le dépôt rapporte l’acquisition de 541 actions par l’exercice d’une option salarié au prix d’exercice de 276,36 $ et de 256 actions par une autre option au prix d’exercice de 166,62 $, toutes deux effectives le 08/09/2025. La personne déclarant a également inscrit ces 541 et 256 actions comme acquisitions non dérivées à ces prix et a vendu 797 actions le même jour à un prix moyen pondéré de 348,81 $. Le dépôt précise en outre que 93 des actions acquises ont été achetées dans le cadre du plan d’achat d’actions de la société depuis le dernier dépôt au titre de la Section 16. Après les opérations déclarées, la détention bénéficiaire est indiquée respectivement à 4 431 ; 4 687 ; et 3 890 actions sur les lignes correspondantes. Les transactions comprennent des attributions annuelles d’options non qualifiées qui acquièrent droit en quatre versements annuels substantiellement égaux.

Insulet Corporation (PODD) — Das Form 4 dokumentiert Insider-Transaktionen von Laetitia Cousin, SVP Regulatory, Quality & Compliance, datiert 08.09.2025. Die Einreichung meldet den Erwerb von 541 Aktien durch Ausübung einer Mitarbeiter-Aktienoption zu einem Ausübungspreis von $276,36 und 256 Aktien durch eine weitere Option zu $166,62, beide mit Wirkung zum 08.09.2025. Die meldepflichtige Person hat diese 541 und 256 Aktien als nicht-derivative Erwerbe zu diesen Preisen angegeben und am selben Tag 797 Aktien zu einem gewichteten Durchschnittspreis von $348,81 verkauft. In der Einreichung wird außerdem offengelegt, dass 93 der erworbenen Aktien seit der letzten Section-16-Meldung über den Aktienkaufplan des Unternehmens erworben wurden. Nach den gemeldeten Transaktionen beträgt das wirtschaftliche Eigentum auf den jeweiligen Zeilen 4.431; 4.687; und 3.890 Aktien. Die Transaktionen umfassen jährliche nicht-qualifizierte Optionszuteilungen, die in vier im Wesentlichen gleichen jährlichen Raten vesten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cousin Laetitia

(Last) (First) (Middle)
C/O INSULET CORPORATION
100 NAGOG PARK

(Street)
ACTON MA 01720

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INSULET CORP [ PODD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Reg, Quality & Compliance
3. Date of Earliest Transaction (Month/Day/Year)
09/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/08/2025 M 541 A $276.36 4,431(1) D
Common Stock 09/08/2025 M 256 A $166.6 4,687 D
Common Stock 09/08/2025 S 797 D $348.81(2) 3,890 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $276.36 09/08/2025 M 541 (3) 02/28/2033 Common Stock 541 $0 542 D
Stock Option (Right to Buy) $166.62 09/08/2025 M 256 (3) 02/27/2034 Common Stock 256 $0 3,876 D
Explanation of Responses:
1. Includes 93 shares acquired under the Insulet Corporation Stock Purchase Plan since the date of the Reporting Person's last Section 16 filing.
2. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $348.40 to $348.93. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
3. Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.
/s/ Patricia K. Dolan, attorney-in-fact 09/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Laetitia Cousin report on Form 4 for PODD?

The Form 4 reports acquisition of 541 shares via an option exercisable at $276.36, acquisition of 256 shares via an option exercisable at $166.62, and a sale of 797 shares at a weighted average price of $348.81 on 09/08/2025.

How many shares did the reporting person own after the transactions?

The filing lists beneficial ownership figures of 4,431, 4,687, and 3,890 shares on the respective reported lines following the transactions.

Were any of the shares acquired through a company plan?

Yes. The filing discloses 93 shares acquired under the Insulet Corporation Stock Purchase Plan since the last Section 16 filing.

What prices applied to the option exercises and sale?

Option exercise prices are $276.36 and $166.62. The sale price reported is a weighted average of $348.81, with individual sale prices in the range $348.40 to $348.93.

Are the option grants subject to vesting conditions?

Yes. The filing states the annual non-qualified stock options vest in substantially equal installments on each of the first four anniversaries of the grant date.
Insulet Corp

NASDAQ:PODD

PODD Rankings

PODD Latest News

PODD Latest SEC Filings

PODD Stock Data

23.77B
70.13M
0.27%
101.79%
2.3%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ACTON